FSSAI notices to Nestle India, Zydus Wellness over ‘misleading claims’ in products
India's food safety regulator, the FSSAI, has issued notices to Nestle India and Zydus Wellness regarding alleged misleading claims on certain food products. Nestle was questioned over promotional claims for infant formulas like Lactogen Pro 1 and Nan Excella Pro, while Zydus Wellness faced scrutiny over Complan advertisements. The companies are required to submit scientific proof to substantiate their marketing claims.
Why it matters
It underscores heightened regulatory scrutiny on commercial infant nutrition and health claims, aiming to protect public health and consumer transparency.
FSSAI notices to Nestle India, Zydus Wellness over ‘misleading claims’ in products left A view of the Nestle logo. File Reuters Reuters https://th-i.thgim.com/public/incoming/6bmy3u/article71608691.ece/alternates/FREE_1200/2026-02-18T141806Z_1175616765_RC2097ADINY3_RTRMADP_3_INFANT-FORMULA-RECALL-NESTLE-DANONE.JPG DENIS BALIBOUSE FILE PHOTO: A view of the logo during the Annual General Meeting of Nestle in Ecublens near Lausanne, Switzerland, April 18, 2024. REUTERS/Denis Balibouse/File Photo The companies have been asked to provide scientific proof to support their advertisements New Delhi The Food Safety and Standards Authority of India (FSSAI) has issued notices to Nestle India and Zydus Wellness over “misleading claims” in certain products and has asked the companies to provide scientific proof to support their advertisements. In a social media post, the FSSAI said notices were sent to Nestle India for misleading claims and non-compliant promotions involving two food products ‘Lactogen Pro 1 Powder’ and ‘Nan Excella Pro Stage 1’.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in